Daniel Vasella
Europe, Basel-Stadt, Switzerland, Basel
Description
Daniel Vasella is the Chairman Of The Board at Numab Therapeutics AG.
Investor Profile
Daniel Vasella has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A rounds (top funding stages).
- Majority of deals are located in Ghana, Switzerland.
- Strong thematic focus on Health Care, Pharmaceutical, Hospital.
Stage Focus
- Series C (50%)
- Series A (50%)
Country Focus
- Ghana (50%)
- Switzerland (50%)
Industry Focus
- Health Care
- Pharmaceutical
- Hospital
- Biotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.